Teva Pharmaceuticals has agreed to hold off launching its knock-off version of Indivior Plc's blockbuster opioid addiction drug until the resolution of a US Court case on another generic rival, Indivior said on Wednesday.
The pair's Indian rival Dr.Reddy's Laboratories is currently locked in a legal battle in the United States to re-launch a cheaper version of the UK drugmaker's Suboxone Film.
Indivior also reiterated its full-year net revenues guidance of $25 million to $50 million from its new opioid addiction drug Sublocade, on which the company has pinned its hopes after the legal battles.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
